InfoMedSearch Newsletters
Breast Cancer

:: September 2014


Welcome to our Monthly Online Newsletter!


View all Treatment articles in our Treatment Report . The most recent articles are listed on top (not in alphabetical order). Click on the Topic on our home page and then the subtopic - Treatment Report. Stay updated on drugs and their side effects, and various other treatments, including exercise, nutrition, and supplements.

Highlighted Articles

Our Highlighted Articles are now being included in our Weekly Featured Articles site. If you have not already signed up for our Alerts newsletter which links to this site, please do so at our sign up page. Stay current and save time. Free access to our Weekly Featured Articles and Weekly Featured Brain Articles.

Clinical Guidelines

AHRQ - Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility (2005)

American Society of Clinical Oncology (ASCO) Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: Guideline Summary (2006)

American Society of Clinical Oncology (ASCO) Patient Guide: Sentinel Lymph Node Biopsy in Early Stage Breast Cancer (2005)

ASCO Patient Guide: HER2 Testing for Breast Cancer (2006)

ESMO - Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC) (2005)

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer (2005)

National Comprehensive Cancer Network (NCCN) Breast Cancer Guideline, Version 1.2007

NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis (2008)

NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian (2007)

NCCN - Breast Cancer Treatment Guidelines for Patients ? Version VII, December 2005

NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction (2008)

NGC - AHRQ - Understanding Breast Cancer Treatment: A Guide for Patients (2005)

NGC - American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. (2005)

NGC - American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor?positive breast cancer: status report 2004. (2004)

NGC - Breast cancer. (2004)

NGC - Breast cancer. (2005)

NGC - Breast cancer treatment. (2004)

NGC - Breast cancer treatment. (2005)

NGC - Breast masses. (2005)

NGC - Clinical guidelines for the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. (2004)

NGC - Common breast problems. (2007)

NGC - Diagnosis of breast disease. (2005)

NGC - Diagnostic imaging in breast cancer. (2006)

NGC - GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER

NGC - Management of breast cancer in women. A national clinical guideline. (2005)

NGC - Palpable breast masses. (2006)

NGC - Procedure guideline for breast scintigraphy. (2004)

NGC - SCREENING FOR BREAST CANCER

NGC - Stage 1 breast carcinoma. (2006)

NGC - The role of taxanes in neoadjuvant chemotherapy for women with non-metastatic breast cancer. (2004)

NGC - The use of magnetic resonance imaging of the breast (MRIB) for screening of women at high risk of breast cancer. (2004)

NGC - Use of bisphosphonates in women with breast cancer. (2004)

NICE - Familial breast cancer (2004)

Internet Sites

Related InfoMedSearch Topics

Related Topics - Highlighted Articles

Menopause

Postmenopausal breast cancer risk and cumulative number of menstrual cycles. (Cancer Epidemiol Biomarkers Prev. 2005) "CONCLUSION: Among women who underwent natural menopause, a higher number of menstrual cycles in lifetime, reflecting a longer exposure to endogenous estrogens, is associated with an increased breast cancer risk."


Environmental Health

Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. (Cancer Epidemiol Biomarkers Prev. 2005) "Polycyclic aromatic hydrocarbons (PAH) are ubiquitous in the environment. We hypothesized that early life exposure to PAHs may have particular importance in the etiology of breast cancer. ? Our study suggests that exposure in early life to high levels of PAHs may increase the risk of postmenopausal breast cancer; however, other confounders related to geography cannot be ruled out."

 

Diagnosis, Imaging, and Screening

 

General Information

 

Risk Factors
Risk Reduction

 

© 2004-2010 InfoMedSearch, LLC. All Rights Reserved. | Design: mqstudio | Disclaimer